Immunogenicity of Milk Protein-Containing Hydrophilic Gel Patch for Epicutaneous Immunotherapy for Milk Allergy
- 16 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pharmaceutical Research
- Vol. 37 (3), 35
- https://doi.org/10.1007/s11095-019-2728-y
Abstract
Purpose Epicutaneous immunotherapy (EPIT) involving the skin's immune system is easy to use, painless and has a low risk of systemic side effects; it can be applied to food allergies that have a high morbidity rate in children. In this study, we evaluated the safety and efficacy of hydrophilic gel patch (HG) for EPIT. Methods Milk protein concentrate (MPC)-containing HG was applied to the skin that maintained a barrier function or formed puncture holes with microneedle, and MPC-specific antibodies were measured. The clinical study was conducted involving patients with severe milk allergy. Results No specific immune response was induced when immunizing to intact skin, and antibody production was observed by forming puncture holes. It was suggested that MPC contained in HG has immunogenicity and a very small amount of MPC was delivered to intact skin. In the clinical study, the symptom induction threshold increased in four of eight subjects, allowing them to consume milk and switch to oral immunotherapy. Although local skin reactions and temporary elevation of specific IgE antibodies were observed, no systemic side effects appeared throughout the study. Conclusions EPIT using HG is a safe method to enable oral administration even in patients with severe milk allergies.This publication has 32 references indexed in Scilit:
- Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patchJournal of Allergy and Clinical Immunology, 2016
- Food allergy: Epidemiology, pathogenesis, diagnosis, and treatmentJournal of Allergy and Clinical Immunology, 2014
- Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in miceProceedings of the National Academy of Sciences of the United States of America, 2013
- Therapies for allergic inflammation: refining strategies to induce toleranceNature Medicine, 2012
- Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheriaVaccine, 2012
- Immunotherapy for allergic rhinitisClinical & Experimental Allergy, 2011
- Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless ratJournal of Controlled Release, 2011
- Epidemiologic risks for food allergyJournal of Allergy and Clinical Immunology, 2008
- THE HIGH-AFFINITY IgE RECEPTOR (FcεRI): From Physiology to PathologyAnnual Review of Immunology, 1999
- Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract1Journal of Allergy and Clinical Immunology, 1997